(13263834), K. H., (5506013), F. X., (586649), L. X., & (2826512), Y. L. (2025). Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.
Dyfyniad Arddull Chicago(13263834), Kaixiang He, Fujiang Xu (5506013), Li Xiang (586649), and Yuhao Luo (2826512). Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.
Dyfyniad MLA(13263834), Kaixiang He, et al. Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.